Breaking News
February 22, 2019 - Growing number of cancer survivors, fewer providers point to challenge in meeting care needs
February 22, 2019 - Innovative compound offers a new therapeutic approach to treat multiple sclerosis
February 22, 2019 - $1.5 million grant to develop opioid treatment program for jail detainees
February 22, 2019 - FDA’s new proposed rule would update regulatory requirements for sunscreen products in the U.S
February 22, 2019 - Most Hip, Knee Replacements Last Decades, Study Finds
February 22, 2019 - Wellness problems prevalent among ob-gyn residents
February 22, 2019 - In the Spotlight: “The world is your oyster in geriatrics”
February 22, 2019 - Successful testing of multi-organ “human-on-a-chip” could replace animals as test subjects
February 22, 2019 - Analysis of cervical precancer shows decline in two strains of HPV
February 22, 2019 - Sugary stent eases suturing of blood vessels
February 22, 2019 - From surgery to psychiatry: A medical student reevaluates his motivations
February 22, 2019 - Is New App From Feds Your Answer To Navigating Medicare Coverage? Yes And No
February 22, 2019 - New pacemakers powered by heartbeats could reduce need for surgery
February 22, 2019 - The United States records highest drug overdose death rates
February 22, 2019 - Phase 1 data reinforce safety profile of new drug for treating Duchenne muscular dystrophy
February 22, 2019 - Vitamin D supplementation less effective in the presence of obesity, shows study
February 22, 2019 - Sarepta Announces FDA Acceptance of Golodirsen (SRP-4053) New Drug Application for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 53
February 22, 2019 - An institutional effort to reduce the amount of opioids prescribed following lumbar surgery
February 22, 2019 - Failure to take statins leads to higher mortality rates | News Center
February 22, 2019 - New study explains why some patients report phantom sensations after limb amputation
February 22, 2019 - First motor-controlled heart valves implanted by Mainz University Medical Center
February 22, 2019 - Novel preclinical model mimics persistent interneuron loss seen in preterm infants
February 22, 2019 - Global health burden of glaucoma has increased, study reveals
February 22, 2019 - A holistic approach key to minimize treatment complexity in patients with interstitial lung disease
February 22, 2019 - 1 in 10 middle-aged Chinese adults are at high risk for heart disease, finds study
February 22, 2019 - More than half a million breast cancer patient’s lives saved by improvements in treatment
February 22, 2019 - Study finds no evidence that tougher policies prevent teenage cannabis use
February 22, 2019 - New blood test detects genetic disorders in fetuses
February 22, 2019 - Lower Self-Perception Observed in Children With Amblyopia
February 22, 2019 - Up to 15 percent of children have sleep apnea, yet 90 percent go undiagnosed
February 22, 2019 - Rare pulmonary defect prompts parents’ nationwide search for answers | News Center
February 22, 2019 - Lesbian and bisexual women at greater risk of being overweight, study finds
February 22, 2019 - UQ research may explain why vitamin D is essential for brain health
February 22, 2019 - Heart Attacks Rising Among Younger Women
February 22, 2019 - How your smartphone is affecting your relationship
February 22, 2019 - Orthopaedic surgeon receives prestigious award, $10 million grant | News Center
February 22, 2019 - New sepsis test could save thousands of lives
February 22, 2019 - Cervical cancer could be eradicated by 2100
February 21, 2019 - Sustained smoking cessation can lower risk of seropositive RA
February 21, 2019 - Thousands with chronic UTIs are not receiving the treatment they need
February 21, 2019 - Are teens getting high on social media? The surprising study seeking the pot-Instagram link
February 21, 2019 - Stanford expands biobank services | News Center
February 21, 2019 - Scientists identify link between drinking contexts and early onset intoxication among adolescents
February 21, 2019 - Strong social support may reduce cardiovascular disease risk in postmenopausal women
February 21, 2019 - Rapid expansion of interventions could prevent up to 13 million cases of cervical cancer within 50 years
February 21, 2019 - Motif Bio Receives Complete Response Letter From The FDA
February 21, 2019 - Researchers map previously unknown disease in children
February 21, 2019 - A skeptical look at popular diets: Going gluten-free
February 21, 2019 - Podcast: KHN’s ‘What The Health?’ How Safe Are Your Supplements?
February 21, 2019 - Factors associated with increased risk of developing surgical site infections
February 21, 2019 - Anticipatory signals in eye movements can help measure attentive capacity, learning with greater precision
February 21, 2019 - Study explores daily exposure to indoor air pollutants
February 21, 2019 - Evening exercise does not negatively affect sleep, may also reduce hunger
February 21, 2019 - Artificial intelligence technique can be used to identify alcohol misuse in trauma setting
February 21, 2019 - Overweight, obesity in adolescence associated with increased risk of renal cancer later in life
February 21, 2019 - BGU develops new AI platform for monitoring and predicting ALS progression
February 21, 2019 - Researchers discover a new promising target to improve HIV vaccines
February 21, 2019 - Brief Anesthesia in Infancy Does Not Mar Neurodevelopment
February 21, 2019 - Gaming system helps with autism diagnosis
February 21, 2019 - Heart Disease: Six Things Women Should Know
February 21, 2019 - More States Say Doctors Must Offer Overdose Reversal Drug Along With Opioids
February 21, 2019 - Researchers explore case studies focused on industries that kill more people than employed
February 21, 2019 - Only half of GP practice buildings are fit for purpose
February 21, 2019 - Intense exercise, fasting and hormones can enhance waste-protein removal, study shows
February 21, 2019 - Scientists can monitor brain activity to predict epileptic seizures few minutes in advance
February 21, 2019 - Study quantifies hepatic and intestinal mRNA expression of Ugt isoforms in rats
February 21, 2019 - ‘Apple-Shaped’ Body? ‘Pear-Shaped’? Your Genes May Tell
February 21, 2019 - Can we repair the brain? The promise of stem cell technologies for treating Parkinson’s disease
February 21, 2019 - Trump Plan To Beat HIV Hits Rough Road In Rural America
February 21, 2019 - PENTAX Medical introduces new electrosurgical and argon plasma coagulation platforms
February 21, 2019 - Trump plan to beat HIV hits rough road in rural America
February 21, 2019 - Eating blueberries every day could help decrease blood pressure
February 21, 2019 - ‘No Second Chances’ report calls for new measures to combat cardiovascular disease in Australia
February 21, 2019 - Mayo clinic researchers discuss local case studies of leprosy
February 21, 2019 - Scientists demonstrate key role of salt in allergic immune reactions
February 21, 2019 - Experts propose revising the criteria for diagnosis of Parkinson’s disease
February 21, 2019 - The med student and the machine
February 21, 2019 - Hey, Hey! Ho, Ho! Is Striking For School Nurses The Way To Go?
February 21, 2019 - Latest research encourages children to move out and learn through physical activity
February 21, 2019 - Proper oral hygiene and regular visits to dentist can promote heart health
Columbia Opioid Symposium Calls for Research, Action

Columbia Opioid Symposium Calls for Research, Action

image_pdfDownload PDFimage_print

Speakers at an opioid symposium sponsored by the Irving Institute for Clinical and Translational Research are, from left, Harold Pincus, MD; Mary Bassett, MD, MPH; Carlos Blanco, MD, PhD; Mark Olfson, MD, MPH; and Frances Levin, MD. (Photo credit: Chris Leary Photography)

Speakers at an opioid symposium this summer at Columbia University Irving Medical Center challenged participants to reverse the crisis’s grim statistics. In the U.S., opioid overdose deaths have nearly quadrupled since 1999 to more than 64,000 per year, and they account for 20 percent of deaths in young adults. Yet according to the Department of Health and Human Services, just 20 percent of individuals with an opioid use disorder receive any kind of treatment.

Reducing opioid use and overdoses will take more research, most speakers emphasized. Already at Columbia and NewYork-Presbyterian Hospital, such work is getting underway. An opioid brainstorm session was convened late last year to foster collaboration among researchers at Columbia, NewYork-Presbyterian Hospital, industry partners, and the community—and led to the formation of working groups focused on prescribing and pain management, addiction treatment, community engagement, and bench-to-bedside research on pain and addiction. (The session was organized by Columbia’s NIH Clinical and Translational Science Award Program and overseen by the Irving Institute for Clinical and Translational Research, a partnership between Columbia and NewYork-Presbyterian.) The meeting coincided with other initiatives—including NewYork-Presbyterian Hospital’s efforts to monitor and alter opioid prescribing and to increase community-based treatment of addiction.

“With these groups, we’re hoping to spark new ideas and new collaborations about how to address the opioid epidemic,” said Muredach Reilly, MBBCh, MSCE, director of the Irving Institute, Herbert and Florence Irving Professor of Medicine at Columbia University Vagelos College of Physicians and Surgeons (VP&S), and an attending physician at NewYork-Presbyterian Hospital.

“We need research and solutions to address the many narratives underlying this crisis—overmedication of chronic pain, undertreatment of opioid use disorder, and systemic medical system, societal, and legal failures—in order to stop people from dying.”

The symposium coincided with the recent launch of the NIH’s HEAL initiative, a $500 million research program to fund interdisciplinary research on addiction and pain.

The participants discussed current approaches toward preventing opioid use disorder and overdose—and how to improve those approaches. Carlos Blanco, MD, PhD, director of epidemiology, services, and prevention research at the National Institute on Drug Abuse, said prevention needs to be a priority, not an afterthought. To do that, he said, more research about who is at risk is needed.

Patients who appear to be most at risk of death from opioid overdose and related problems are those being treated for chronic pain, according to research from Mark Olfson, MD, MPH, professor of psychiatry at VP&S. “Many of these deaths occurred in people who had been prescribed opioids in combination with benzodiazepines in the final month of life, showing us that we have a fair amount of work to do to improve the safety of pain management,” he said.

“We have a fair amount of work to do to improve the safety of pain management,” said Mark Olfson, MD, MPH. (Photo credit: Chris Leary Photography)

The crisis also has affected its victims in other ways that we are just beginning to understand. “A great deal of attention has been placed on the risk of overdose deaths following nonfatal overdoses, but our latest study showed that individuals who survive a nonfatal overdose are also at increased risk of dying from a number of medical conditions, including circulatory and respiratory diseases, suicide, and HIV,” said Olfson.

We need to be more aggressive about using MAT, which will involve overcoming numerous barriers.

For individuals with opioid use disorder, proven treatments are available but underused. Medication addiction therapy (MAT)—including naltrexone, buprenorphine, and methadone—reduces the risk of relapse, overdose, and mortality, said Frances Levin, MD, the Kennedy-Leavy Professor of Psychiatry at VP&S and chief of the Division on Substance Use Disorders at Columbia University Irving Medical Center/New York State Psychiatric Institute. But out of the 20 percent of individuals with opioid use disorder who get treatment, less than a third are treated with MAT. “We need to be more aggressive about using MAT, which will involve overcoming numerous barriers to using and prescribing these medications,” said Levin, who also is a psychiatrist at NewYork-Presbyterian.

MAT medications are often hard to access outside of major metropolitan areas, explaining one barrier. Patients also must remain abstinent for a week before one of the medications (naltrexone) can be used. To remedy these problems, Levin said that faculty at Columbia are working to expand implementation of MAT in community-based settings and to improve naltrexone induction. Other treatments, including opioid vaccines, game-based interventions, and phrenic nerve stimulation to reverse overdose, are also being developed.

Rural America garners much of the media attention on the opioid epidemic, but cities are also affected. Since the introduction of fentanyl to the New York City market a few years ago, someone in our city dies of an opioid overdose every seven hours, said Mary Bassett, MD, MPH, commissioner of the New York City Department of Health and Mental Hygiene.

Slide from NYC Department of Health and Mental Hygiene

New York City has been tackling the opioid crisis on a variety of fronts. Mayor DeBlasio committed $60 million to train 1,500 providers in MAT prescription, open syringe exchange sites in areas most affected by overdose deaths, and develop media campaigns to destigmatize addiction treatment. The investment also will expand the city’s Relay overdose response system, which positions wellness advocates in hospital emergency rooms to guide overdose survivors toward treatment. Bassett also reported that, following a directive from the mayor’s office, 960 pharmacies now offer naloxone, which reverses opioid overdose, without a prescription.

The symposium ended with two concurrent sessions and panel discussions. One session, led by Beatrice Ellerin, director of the Healthcare and Pharmaceutical Management Program at the Columbia Business School, focused on the industry response to the crisis; another, led by the Community Engagement Core Resource of the Irving Institute with NewYork-Presbyterian Hospital, Columbia School of Social Work, and the Washington Heights Corner Project, focused on community responses to the crisis.

In the months ahead, the Irving Institute and partners will continue to challenge and engage researchers, government, and industry and community leaders in tackling the opioid crisis through research and action. “By sparking new ideas and new collaborations, providing seed funding for initial steps, and empowering our working groups to respond to the NIH Heal Initiative and other funding opportunities, we will continue to work with our partners to facilitate research and implementation of science-based solutions to address the many facets of this national crisis,” concluded Reilly.

Tagged with:

About author

Related Articles